4-Methylthiobenzoic acid protection against cisplatin nephrotoxicity: Antioxidant system

Fundamental and Applied Toxicology

Volumn 32, Issue 2, 1996, Pages 278-284

  Husain, K ^a   Morris, C ^a   Whitworth, C ^a   Trammel, G L ^b   Rybak, L P ^a   Somani, S M ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ILLINOIS AT SPRINGFIELD   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CATALASE; CISPLATIN; GLUTATHIONE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; SUPEROXIDE DISMUTASE;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG TISSUE LEVEL; ENZYME ACTIVITY; INTRAPERITONEAL DRUG ADMINISTRATION; LIPID PEROXIDATION; MALE; NEPHROTOXICITY; NONHUMAN; RAT;

ANIMALIA; FELIS CATUS; RATTUS NORVEGICUS;

EID: 85033043595     PISSN: 02720590     EISSN: None     Source Type: Journal    
DOI: 10.1006/faat.1996.0131     Document Type: Article

References (39)

1. Aebi, H. (1984). Catalase in vitro. Methods Enzymol. 105, 121-126.
2. Anderson, M. E., Naganuma, A., and Meister, A. (1990). Protection against cisplatin toxicity by administration of glutathione ester. FASEB J. 4, 3251-3255.
3. Baldew, G. S., Mol, J. G., de-Kanter, F. J., and van-Barr, B., de-Goeij, J. J., and Vermeulen, N. P. (1991). The mechanism of interaction between cisplatin and selenite. Biochem. Pharmacol. 41, 1429-1437.
4. Ban, M., Hettich, D., and Huguet, N. (1994). Nephrotoxicity mechanism of cis-platinum (II) diamine dichloride in mice. Toxicol. Lett. 71, 161-168.
5. Basinger, M. A., Jones, M. M., and Holscher, M. A. (1990). L-Methionine antagonism of cis-platinum-induced nephrotoxicity. Toxicol. Appl. Pharmacol. 103, 1-15.
6. Boogaard, P. J., Lempers, E. L., Mulder, G. J., and Meerman, J. H. N. (1991). 4-Methylthiobenzoic acid reduces cisplatin nephrotoxicity in rats without compromising anti-tumor activity. Biochem. Pharmacol. 41, 1997-2003.
7. Bull, J. M. C., Strebel, F., Sunderland, B. A., Bulger, R. E., Edwards, M., Siddik, Z. H., and Newman, R. A. (1988). O-(β-Hydroxyethyl)-rutoside-mediated protection of renal injury associated with cis-diamminedichloroplatinum (II)/hyperthermia treatment. Cancer Res. 48, 2239-2244.
8. Cozzaglio, L., Doci, R., Colla, G., Zunino, F., Casciarri, G., and Gennari, L. (1990). A feasibility study of high-dose cisplatin and 5-fluorouracil with glutathione protection in the treatment of advanced colorectal cancer. Tumori 76, 590-594.
9. DeWoskin, R. S., and Riviere, J. E. (1992). Cisplatin-induced loss of kidney copper and nephrotoxicity is ameliorated by single dose diethyldithiocarbamate, but not mesna. Toxicol. Appl. Pharmacol. 112, 182-189.
10. Di Re, F., Bohm, S., Oriana, S., Spatti, G. B., and Zunino, F. (1990). Efficacy and safety of high-dose cisplatin and cyclophosphamide with glutathione protection in the treatment of bulky advanced epithelial ovarian cancer. Can. Chemother. Pharmacol. 25, 355-360.
11. Flohe, L., and Gunzler, W. (1984). Assays of glutathione peroxidase. Methods Enzymol., 105, 114-121.
12. Fontanelli, R., Spatti, G., Raspagliesi, F., Zunino, F., and DiRe, F. (1992). A preoperative single course of high dose cisplatin and bleomycin with glutathione protection in bulky stage IB/II carcinoma of the cervix. Ann. Oncol. 3, 117-121.
13. Gandara, D. R., Perez, E. A., Weibe, V., and DeGregorio, M. W. (1991). Cisplatin chemoprotection and rescue: Pharmacologic modulation of toxicity. Semin. Oncol. 18, 49-55.
14. Hamers, F. P. T., Brakkee, J. H., Cavalletti, E., Tedeschi, M., Marmonti, L., Pezzoni, G., Neijt, J. P., and Gispen, W. H. (1993). Reduced glutathione protects against cisplatin-induced neurotoxicity in rats. Cancer Res. 53, 544-549.
15. Hannemann, J., and Baumann, K. (1988). Cisplatin-induced lipid peroxidation and decrease of gluconeogenesis in rat kidney cortex: Different effects of antioxidants and radical scavengers. Toxicology 51, 119-132.
16. Heyman, S. N., Spokes, K., Egorin, M. J., and Epstein, F. (1993). Glycine reduces early renal parenhcymal uptake of cisplatin. Kidney Int. 43, 1226-1228.
17. Hidaka, S., Tsurupka, M., Funakoshi, T., Shimada, H., Kivozumi, M., and Kolima, S. (1994). Protective effects of dithiocarbamates against renal toxicity of cis-diamminedichloroplatinum in rats. Renal Failure 16, 337-349.
18. Jones, M. M., Basinger, M. A., and Holscher, M. A. (1991). Thioether suppression of cisplatin nephrotoxicity in the rat. Anticancer Res. 11, 449-454.
19. Kameyama, Y., and Gemba, M. (1991). Cisplatin-induced injury to calcium uptake by mitochondria in glutathione-depleted slices of rat kidney cortex. Jpn. J. Pharmacol. 55, 174-176.
20. Litterst, C. L., and Schweitzer, V. G. (1988). Covalent binding of platinum to renal protein from sensitive and resistant guinea pigs treated with cisplatin: Possible role in nephrotoxicity. Res. Commun. Chem. Pathol. Pharmacol. 61, 35-48.
21. Markman, M., D'Acquito, R., Iannoti, N., Kois, H., Hakes, T., Bajorin, D., Bosl, G., Reichman, B., Casper, E., and Magill, G. (1991). Phase I trial of high dose intravenous cisplatin with simultaneous intravenous sodium thiosulphate. J. Can. Res. Clin. Oncol. 117, 151-155.
22. McFariss, W., and Reed, D. J. (1987). High performance liquid chromatography of thiols and disulfides: Dinitrophenol derivatives. Methods Enzymol. 143, 101-109.
23. Misra, H. P., and Fridovich, I. (1972). The role of superoxide anion in the autooxidation of epinephrine and a simple assay for superoxide-dismutase. J. Biol. Chem. 247, 3170-3175.
24. Mistry, P., Merazga, Y., Spargo, D. J., Riley, P. A., and McBrien, D. C. H. (1991). The effects of cisplatin on the concentration of protein thiols and glutathione in the rat kidney. Cancer Chemother. Pharmacol. 28, 277-282.
25. Ohkawa, H., Ohishi, N., and Yagi, K. (1979). Assay for lipid peroxides in animals and tissues by thiobarbituric acid reaction. Anal. Biochem. 95, 351-358.
26. Pigeolet, E., Corbisier, P., Houbion, A., Lambert, D., Michiels, C., Raes, M., Zachary, M. D., and Ramacle, J. (1990). Glutathione peroxidase, superoxide dismutase and catalase inactivation by peroxides and oxygen derived free radicals. Mech. Ageing Dev. 51, 283-297.
27. Ravi, R., Somani, S. M., and Rybak, L. P. (1995). Mechanism of cisplatin ototoxicity: Antioxidant system. Pharmacol. Toxicol. 76, 386-394.
28. Read, S. M., and Northcole, D. H. (1981). Minimization of variation in the response to different protein of the Coomassie blue G dye-binding assay for protein. Anal. Biochem. 116, 53-64.
29. Rybak, L. P., Ravi, R., and Somani, S. M. (1995). Mechanism of protection by diethyldithiocarbamate against cisplatin ototoxicity: Antioxidant system. Fundam. Appl. Toxicol. 26, 293-300.
30. Somani, S. M., Ravi, R., and Rybak, L. P. (1995). Diethyldithiocarbamate protection against cisplatin nephrotoxicity: Antioxidant system. Drug Chem. Toxicol. 18, 151-170.
31. Sugihara, K., Nakano, S., Koda, M., Tanaka, K., Fukuishi, N., and Gemba, M. (1987). Stimulatory effect of cisplatin on production of lipid peroxidation in renal tissues. Jpn. J. Pharmacol. 43, 247-252.
32. Sugiyama, S., Hayakawa, M., Kato, T., Hanki, Y., Shimizu, K., and Ozawa, T. (1989). Adverse effects of anti-tumor drug, cisplatin, on rat kidney mitochondria: Disturbances in glutathione peroxidase activity. Biochem. Biophys. Res. Commun. 159, 1121-1127.
33. Tognella, S. (1990). Pharmacological interventions to reduce platinum-induced toxicity. Cancer Treat. Rev. 17, 139-142.
34. Walker, E. M. Jr., Fazekas-May, M. A., Heard, K. W., Yee, S., Montague, D., and Jones, M. M. (1994). Prevention of cisplatin-induced toxicity by selected dithiocarbamates. Ann. Clin. Lab. Sci. 24, 121-133.
35. Wolfgang, G. H. I., Dominick, M. A., Walsh, K. M., Hoeschele, J. D., and Pegg, D. G. (1994). Comparative nephrotoxicity of a novel platinum compound, cisplatin and carboplatin in male Wistar rats. Fundam. Appl. Toxicol. 22, 73-79.
36. Yuhas, J. M., and Culo, F. (1980). Selective inhibition of the nephrotoxicity of cis-dichlorodiammineplatinum (II) by WR-2721 without altering its antitumor properties. Can. Treat. Rep. 64, 57-64.
37. Younes, M., and Siegers, C. P. (1981). Mechanistic aspects of enhanced lipid peroxidation following glutathione depletion in vivo. Chem.-Biol. Interact. 34, 257-266.
38. Zhang, J. G., and Lindup, W. E. (1993). Role of mitochondria in cisplatin induced oxidative damage exhibited by rat renal cortical slices. Biochem. Pharmacol. 45, 2215-2222.
39. Zunino, F., Pratesi, G., Micheloni, A., Cavalletti, E., Sala, F., and Tofanetti, O. (1989). Protective effect of reduced glutathione against cisplatin-induced renal and systemic toxicity and its influence on the therapeutic activity of the antitumor drug. Chem.-Biol. Interact. 70, 89-101.